On Friday, Roivant Sciences Ltd (NASDAQ: ROIV) was -3.54% drop from the session before settling in for the closing price of $11.03. A 52-week range for ROIV has been $8.73 – $13.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 29.37% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at -109.96%. With a float of $438.55 million, this company’s outstanding shares have now reached $719.63 million.
In an organization with 908 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 89.03%, operating margin of -1027.4%, and the pretax margin is -594.75%.
Roivant Sciences Ltd (ROIV) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Roivant Sciences Ltd stocks. The insider ownership of Roivant Sciences Ltd is 38.54%, while institutional ownership is 68.16%. The most recent insider transaction that took place on May 07 ’25, was worth 6,987,500. In this transaction 10% Owner of this company sold 625,000 shares at a rate of $11.18, taking the stock ownership to the 39,174,611 shares. Before that another transaction happened on May 06 ’25, when Company’s 10% Owner sold 273,959 for $11.47, making the entire transaction worth $3,142,310. This insider now owns 39,799,611 shares in total.
Roivant Sciences Ltd (ROIV) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -109.96% per share during the next fiscal year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
You can see what Roivant Sciences Ltd (ROIV) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 37.91. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 77.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.14, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -1.12 in one year’s time.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Let’s dig in a bit further. During the last 5-days, its volume was 5.87 million. That was inferior than the volume of 5.94 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 16.42%. Additionally, its Average True Range was 0.38.
During the past 100 days, Roivant Sciences Ltd’s (ROIV) raw stochastic average was set at 54.73%, which indicates a significant increase from 28.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.73% in the past 14 days, which was higher than the 35.38% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.53, while its 200-day Moving Average is $11.26. However, in the short run, Roivant Sciences Ltd’s stock first resistance to watch stands at $11.00. Second resistance stands at $11.36. The third major resistance level sits at $11.55. If the price goes on to break the first support level at $10.45, it is likely to go to the next support level at $10.26. The third support level lies at $9.90 if the price breaches the second support level.
Roivant Sciences Ltd (NASDAQ: ROIV) Key Stats
There are 713,549K outstanding shares of the company, which has a market capitalization of 7.59 billion. As of now, sales total 124,800 K while income totals 4,349 M. Its latest quarter income was 9,020 K while its last quarter net income were 169,380 K.
